Heart failure frequently complicates congenital heart disease (CHD) in children and adults. In patients with end-stage disease, mechanical circulatory support may improve survival, quality of life, and serve as bridge to cardiac transplantation. There are many ethical issues surrounding the use of mechanical circulatory support in patients with CHD including the use of prospective and randomized trials, proper oversight of new therapies, and transparency in reporting. Additionally, there are ethical considerations relevant to the greater society as these therapies are highly resource intensive in a resource-limited society. This article will review the burden of disease of heart failure in patients with CHD, the challenges of mechanical circulatory support and heart transplantation, and the ethical considerations and problems that arise for this population.
HoffmanJIKaplanS. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900.
2.
WilliamsRGPearsonGDBarstRJ, Report of the national heart, lung, and blood institute working group on research in adult congenital heart disease. J Am Coll Cardiol. 2006;47(4):701–707.
3.
RossanoJWKimJJDeckerJA, Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012;18(6):459–470.
4.
RodriguezFHMoodieDSParekhDR, Outcomes of heart failure related admissions in adults with congenital heart disease in the United States: a population based study (abstract). J Am Coll Cardiol. 2011;57:E460.
5.
ShaddyREBoucekMMHsuDT, Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298(10):1171–1179.
6.
KirkREdwardsLBKucheryavayaAY, The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Heart Transplantation Report—2011. J Heart Lung Transplant. 2011;30(10):1095–1103.
7.
StehlikJEdwardsLBKucheryavayaAY, The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report—2011. J Heart Lung Transplant. 2011;30(10):1078–1094.
8.
AlmondCSThiagarajanRRPierceyGE, Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119(5):717–727.
HuntSAAbrahamWTChinMH, ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154–e235.
11.
MoralesDLAlmondCSJaquissRD, Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011;30(1):1–8.
12.
MacklingTShahTDimasV, Management of Single-Ventricle Patients With Berlin Heart EXCOR Ventricular Assist Device: Single-Center Experience. Artif Organs. 2012;36(6):555–559.
13.
BlumeEDNaftelDCBastardiHJDuncanBWKirklinJKWebberSA. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006;113(19):2313–2319.
CopelandJGCopelandHGustafsonM, Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg. 2012;143(3):727–734.
16.
SlaughterMSRogersJGMilanoCA, Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–2251.
17.
SeyfarthMSibbingDBauerI, A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–1588.
18.
RoseEAGelijnsACMoskowitzAJ, Long-term use of a left ventricular assist device for end-stage heart failureN Engl J Med. 2001;345(20):1435–1443.
19.
HetzerRAlexi-MeskishviliVWengY, Mechanical cardiac support in the young with the Berlin Heart EXCOR pulsatile ventricular assist device: 15 years' experience. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006:99–108.
20.
ReinhartzOStillerBEilersRFarrarDJ.Current clinical status of pulsatile pediatric circulatory supportASAIO J. 2002;48(5):455–459.
21.
StillerBHetzerRWengY, Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant. 2003;22(11):1201–1208.
22.
ArabiaFATsauPHSmithRG, Pediatric bridge to heart transplantation: application of the Berlin Heart, Medos and Thoratec ventricular assist devices. J Heart Lung Transplant. 2006;25(1):16–21.
23.
ImamuraMDosseyAMProdhanP, Bridge to cardiac transplant in children: Berlin Heart versus extracorporeal membrane oxygenation. Ann Thorac Surg. 2009;87(6):1894–1901.
24.
AlmondCSBuchholzHMassicotteP, Berlin heart EXCOR pediatric ventricular assist device investigational device exemption study: study design and rationale. Am Heart J. 2011;162(3):425–435.
LawSPKimJJDeckerJA, Hospital charges for pediatric heart transplant hospitalizations in the United States from 1997 to 2006. J Heart Lung Transplant. 2012;31(5):485–491.
27.
SlaughterMSBosticRTongKRussoM, Rogers JG Temporal changes in hospital costs for left ventricular assist device implantation. J Card Surg. 2011;26(5):535–541.
28.
RogersJGBosticRRTongKBAdamsonRRussoMSlaughterMS. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail. 2012;5(1):10–16.
29.
MorenoSGNovielliNCooperNJ. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant. 2012;31(5):450–458.
30.
SteinMLRobbinsRSabatiAA, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: the Stanford experience. Circ Heart Fail. 2010;3(6):682–688.
